Actavis Plans Corporate Name Change to Allergan

ophthalmologytimes.modernmedicine.com

From www.dddmag.com – February 18, 2015

Actavis will change the company name after the completed acquisition of Allergan.

Actavis, the world’s third-largest generics prescription drug manufacturer, also markets a broad portfolio of branded pharmaceuticals and is developing and marketing biosimilars. After the acquisition of Allergan, producer of the successful Botox, Actavis announced that it intends to use the Allergan name as its corporate name and for its global branded pharmaceutical portfolio, and will retain the Actavis name for select geographic regions and product portfolios.